| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2009;53:42.)
© 2009 American Heart Association, Inc.
Original Articles |
From the Division of Endocrinology, Metabolism, and Nephrology (K.I., N.O., C.T., T.K., T.S., H.I.), Department of Internal Medicine, Keio University School of Medicine, Tokyo; Department of Nephrology (H.K.), National Defense Medical College, Tokorozawa, Saitama; Department of Pathology (T.N., Y.H.), Shimane University School of Medicine, Izumo; and Department of Physiology (H.O.), Showa University School of Medicine, Tokyo, Japan.
Correspondence to Kamon Iigaya, Discipline of Physiology, F13, University of Sydney, New South Wales 2006, Australia. E-mail kamon{at}physiol.usyd.edu.au
| Abstract |
|---|
|
|
|---|
Key Words: sympathetic nervous system congenic rat angiotensin II stress RVLM neurons
| Introduction |
|---|
|
|
|---|
In the present study, we used reciprocal congenic strains constructed to evaluate the effect of the blood pressure QTL on Chr-1 on the electrophysiological activities of RVLM neurons in the absence of any influence from blood pressure and the higher brain center in the hypothalamus. The basal activity and response to Ang II superfusion were recorded in a single neuron using the whole-cell patch-clamp technique.
| Materials and Methods |
|---|
|
|
|---|
WKY/Izm and SHRSP/Izm rats were provided by the Disease Model Cooperative Research Association (Kyoto, Japan). The genomic constructs of the 4 strains used in this study are shown in References 4 and 5. The congenic rats were maintained in the Keio University School of Medicine Animal Laboratory Center. All of the rats were fed a standard laboratory chow and tap water ad libitum and kept in a room maintained at a constant temperature of 25°C. The experimental protocols were approved by the Keio University School of Medicine Animal Research Committee, in compliance with Japanese Law (No. 105).
Recording of Electrophysiological Activities
Experiments were performed on brain stem-spinal cord preparations obtained from 0- to 4-day-old rats. Under deep ether anesthesia, the brain stem and spinal cord were isolated and sectioned at the second thoracic nerve root (Th2) level, as described previously.11,14,15 The preparation was continuously superfused at 2 to 3 mL/min with a standard solution consisting of (in mmol/L) 124.0 NaCl, 5.0 KCl, 2.4 CaCl2, 1.3 MgCl2, 26.0 NaHCO3, 1.2 KH2PO4, and 30.0 D-glucose and equilibrated with 95% O2 and 5% CO2 (pH7.4), at 26°C to 27°C.
Intracellular recordings using the whole-cell patch-clamp technique were performed as follows: a patch electrode was filled with the following pipette solution (mmol/L): 130 K-gluconate, 10 EGTA, 10 HEPES, 2 Na2-ATP, 1 CaCl2, 1 MgCl2, and 0.5% lucifer-yellow (Aldrich Chemical [pH 7.2 to 7.3], adjusted with KOH). A patch-clamp amplifier (Axopatch 1D, Axon Instruments) was used to record the membrane potential. Before starting the intracellular recordings, the firing patterns were checked using extracellular recordings. RVLM neurons exhibiting discharges that were synchronized with the simultaneously recorded phrenic nerve activity were assumed to be respiratory neurons and were excluded from the study. The membrane potential was recorded using the current-clamp technique (20-pA increments from –100 to 20 pA, 500-ms duration) and was corrected for the junctional potential at the tip of the pipettes (–-11 mV). The basal membrane potential and the firing rate were recorded over 10 minutes. The input resistance was calculated from the current-voltage curve. The membrane potential was shifted to –50 mV because of the negative current. One RVLM neuron per preparation was used in the experiment.
To evaluate the responses to Ang II, we superfused the brain stem-spinal cord preparation for 20 minutes with Ang II (6 µmol/L, Sigma-Aldrich) dissolved in a standard solution and recorded the changes in the membrane potential and in the input resistance of the RVLM neurons. Li and Guyenet16 used a bath application of 0.3 to 1.0 µmol/L of Ang II in their slice preparations. In an earlier study from our laboratory, we used 1, 3, and 12 µmol/L of Ang II to examine the dose responsiveness of RVLM neurons in a brain stem-spinal cord preparation, in which the target neurons were located 100 µm from the surface of the preparation.11 Based on these results, we selected the dosage of 6 µmol/L of Ang II, because the distance from the surface of the preparation to the RVLM neurons makes it difficult for Ang II to reach the target neurons.
We then performed superfusion with a mixture of Ang II (6 µmol/L) and tetrodotoxin (50 µmol/L; Wako Pure Chemical Industries). Tetrodotoxin was used to block every synaptic input to the RVLM neurons. The intermediolateral cell column neurons were stimulated with a stainless-steel electrode (5 to 15 V, 100 ms, single pulse) to identify the RVLM bulbospinal neurons. RVLM bulbospinal neurons showing antidromic action potentials after intermediolateral cell column stimulation were used in the experiments.17 Lucifer yellow was allowed to diffuse spontaneously or by iontophoresis into the neurons during the intracellular recordings to verify the location of the neurons examined.18 All of the data were recorded and analyzed using PowerLab (AD Instruments). After the addition of tetrodotoxin, we first confirmed the disappearance of phrenic nerve activity (
15 to 20 minutes after the addition of tetrodotoxin) and then added Ang II to the superfusate. Superfusion with Ang II induced depolarization in the bulbospinal neurons of the RVLM after a 1- or 2-minute latency period.
Statistics
All of the data were represented as the means±SDs. Differences between the WKY and WKYpch1.0 rats or between the SHRSPwch1.0 and SHRSP rats were examined using independent t tests. A value of P<0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
In the regularly firing neurons, the basal membrane potential was significantly less negative in the WKYpch1.0 rats (–46.4±2.3 mV) than in the WKY rats (–55.4±5.6 mV). The basal membrane potential of the SHRSPwch1.0 rats (–47.8±2.6 mV) was similar to that of the SHRSP rats (–45.4±3.6 mV). The firing rate did not differ between the WKYpch1.0 and WKY rats or between the SHRSPwch1.0 and SHRSP rats.
As shown in Figure 2, the same trend was observed in the irregularly firing neurons of the RVLM; the basal membrane potential was significantly less negative in the WKYpch1.0 rats (–49.3±3.0 mV) than in the WKY rats (–57.0±1.0 mV; P<0.01). The basal membrane potential of the SHRSPwch1.0 rats (–51.3±3.2 mV) was similar to that of the SHRSP rats (–50.0±0.0 mV). The firing rate did not differ between the WKYpch1.0 and WKY rats or between the SHRSPwch1.0 and SHRSP rats.
The input resistance of the regularly and irregularly firing neurons was also not significantly different among the 4 strains (data not shown).
Response to Ang II
Superfusion with Ang II (6 µmol/L) induced depolarization in the bulbospinal neurons of the RVLM after a 1- or 2-minute latency period. Repolarization toward the basal level was then observed over the next 2 or 3 minutes; this repolarization was considered to represent the desensitization of the neurons. We, thus, quantified the magnitude of the maximal depolarization.
The magnitude of the depolarization of the RVLM neurons from WKYpch1.0 rats during Ang II superfusion was +4.1±2.3 mV, which was significantly larger than that of the neurons from WKY rats (Figure 3). The depolarization of the RVLM neurons from SHRSPs was significantly larger than that of the neurons from SHRSPwch1.0 rats. Of note, the depolarization was statistically significant in the 2 strains (WKYpch1.0 and SHRSP) that possess the SHRSP-derived fragment of the Chr-1 QTL.
|
In the next experiment, which used a potent inhibitor of synaptic transmission, tetrodotoxin, we examined whether the Ang II effect was mediated through presynaptic or postsynaptic pathways. After the administration of tetrodotoxin, we first confirmed the disappearance of phrenic nerve activity and then added Ang II to the superfusate. The average magnitude of the depolarization of the neurons from WKYpch1.0 rats during superfusion with tetrodotoxin and Ang II was significantly larger than that of the neurons from WKY rats (Figure 4). Meanwhile, the average magnitude of the depolarization of the neurons from SHRSPs was also significantly larger than that of the neurons from SHRSPwch1.0 rats. These differences in depolarization were basically the same as those obtained in the experiments without tetrodotoxin, and the neurons from SHRSPs and WKYpch1.0 rats showed a significantly greater depolarization than those from the respective counterpart rats.
|
| Discussion |
|---|
|
|
|---|
In regularly firing neurons, the basal membrane potential differed significantly between neurons from WKY and WKYpch1.0 rats (Figure 1). Considering the genomic composition of the congenic strain (WKYpch1.0), this observation suggests that genes responsible for this interstrain difference are located both inside and outside of the QTL. Furthermore, the lack of a difference between neurons from SHRSPs and SHRSPwch1.0 rats implies that the effects of these genes are not additive, suggesting that they may be involved in the same biological process, just as in the case of the blood pressure QTLs in Dahl salt-sensitive rats.19
In the irregularly firing neurons, we obtained a similar result regarding the difference in the basal membrane potential and no differences in the firing rate (Figure 2). These results can probably be explained by the fact that a larger number of synaptic inputs modulates the firing rate in irregularly firing neurons.14 Nevertheless, a similar interstrain difference in the membrane potential was observed in neurons with different properties, suggesting that this genetic effect is ubiquitous in RVLM neurons.
The Ang II–induced depolarization and increase in the firing rate are shown in Figure 3. Of particular importance, these responses depended largely on the genotype of the congenic fragment, irrespective of the background genome; the 2 strains with the congenic fragment originating from SHRSPs (WKYpch1.0 and SHRSP) showed a significantly greater depolarization than the rats containing the congenic fragment originating from WKY rats (WKY and SHRSPwch1.0). This observation suggests that the responsiveness of the RVLM neurons to Ang II was largely determined by the gene(s) located in the QTL.
WKYpch1.0 rats have been shown repeatedly to have exaggerated sympathetic responses to different types of stress.5–7 Considering a recent observation that the Ang II type 1 receptor in the RVLM mediates activating the sympathetic nervous system by emotional stress, resulting in an increase in blood pressure in conscious rabbits,10 it is quite attractive to hypothesize that a gene (or genes) in the Chr-1 QTL affects (affect) the responsiveness of the sympathetic nervous system to stress through an Ang-II–mediated system in the RVLM. Supporting this hypothesis, Yamazato et al7 reported that the hyperresponsiveness of blood pressure and renal sympathetic nerve activity to air-jet stress in WKYpch1.0 rats was inhibited by the intracerebroventricular injection of an Ang II receptor blocker.
Based on the results of the present study, we suspect that the basal membrane potential in RVLM neurons is affected primarily by age and background genome, whereas the response to Ang II in RVLM neurons depends on the blood pressure QTL of Chr-1. The depolarization of the RVLM neurons by Ang II superfusion was statistically significant in the neonatal WKYpch1.0 and SHRSPs but not in the neonatal WKY and SHRSPwch1.0 rats. Our data are supported by the results reported by Yamazato et al,7 who showed that increases in renal sympathetic nerve activity in response to air-jet stress were significantly larger in 4-week–old WKYpch1.0 and SHRSPs than in 4-week–old WKY rats and that the sympathoexcitation of WKYpch1.0 rats was similar to that of SHRSPs. The depolarization of RVLM neurons by Ang II shown in our study may account for the increases in sympathetic nerve activity and blood pressure in response to air-jet stress, because the intracerebroventricular injection of Ang II receptor blocker candesartan reduced the sympathoexcitatory and pressor responses.7 Also, a report from Cui et al5 demonstrated that the increase in systolic blood pressure in response to restraint stress in 16- to 20-week-old WKYpch1.0 rats was larger than that of WKY rats. These compatible data for different rat ages and from 3 different laboratories strongly suggest that the genes in the Chr-1 QTL of SHRSPs are responsible for the depolarization response of RVLM neurons to Ang II in neonatal WKYpch1.0 and SHRSPs, the increase in peripheral sympathetic activity in response to air-jet stress in 4-week-old WKYpch1.0 and SHRSPs, and the pressor response to restraint stress in 16- to 20-week-old WKYpch1.0 rats. However, these data do not suggest that age is responsible for the stress responses. In contrast, the basal blood pressures of WKY and WKYpch1.0 rats seem to be determined largely by age and also by genes both inside and outside the QTL.
In some cases, the effects of the QTL region on blood pressure were asymmetrical in reciprocal congenic strains for hypertensive QTLs. As Rapp20 pointed out previously, strains with congenic fragments from the Dahl salt-sensitive rat on a background of normotensive strains did not show a significant increase in blood pressure, whereas congenic rats with the reversed genotype showed an obvious reduction. Consistent with this finding, WKYpch1.0 rats showed little, if any, increase in blood pressure, whereas SHRSPwch1.0 rats showed a large decrease.3,13 This asymmetrical nature of the effects of QTLs on blood pressure was probably caused by gene-gene interactions, which convoluted the analyses. In contrast, reciprocal genetic effects like the one observed in the present study suggest a mendelian control of phenotypes: the genotype (or the haplotype) of a single gene (or a cluster of genes) had a major effect on the phenotype, independent of the genetic background.21,22 Such a phenotype may be regulated by the gene(s) in a more direct manner and may be useful for speculating the functions of the gene(s).
Because tetrodotoxin blocks all synaptic transmissions, the observation that the addition of tetrodotoxin did not change the responsiveness to Ang II further implied that the interstrain difference in the responsiveness was intrinsic (or postsynaptic) in the RVLM neurons. A previous study of Sumners et al23 reported that the exaggerated reactivity of RVLM neurons to Ang II in spontaneously hypertensive rats was because of an increase in the number of Ang II receptors on the RVLM neurons, which then induced oxidative stress and activated signal transduction via G proteins. It would be interesting to investigate the underlying intracellular mechanisms of the Ang II–dependent activation of RVLM neurons using congenic strains.
The blood pressure QTL on rat Chr-1 is quite large and contains hundreds of genes and expressed sequence tags.5,13 Among them, however, several interesting candidates were found when the putative roles of the genes in the sympathetic nervous system were considered. These genes include Arix, a transcription factor regulating the development of the sympathetic nervous system, as well as the expression of dopamine β-hydroxylase24–26; Ntrk3, a receptor for neurotropin 327; Arrb1, a cofactor regulating the internalization of the β-adrenergic receptors and angiotensin receptors28; Nox4, a subunit of NADPH oxidase29; and Homer 2, a regulator of the metabolic glutamate receptors.30,31 In future studies, it will be necessary to reduce the number of candidate genes using both their positional and functional information to identify the responsible gene(s) and to confirm the roles of increased RVLM activity in the pathogenesis of hypertension.
The main limitation of this study is the lack of data regarding how RVLM neuron activity may (or may not) differ between strains in older animals and how this possible difference may be correlated with blood pressure. We hope to measure the RVLM neuron activity of both young and old rats in the future. To demonstrate that these early differences in RVLM neuron activity are causally related to stress-related differences in blood pressure, we should have compared the RVLM activity of older congenic and parental rats. Ideally, the electrophysiological properties of RVLM and the blood pressure, heart rate, and renal sympathetic nerve activity should be simultaneously examined in neonatal and older rats in vivo, and the changes in these parameters in response to various stressors should be determined. However, because the contact between the targeted neurons and the patch pipette is impaired by the increase in glial cells and astrocytes that occurs in rats older than 2 weeks of age, intracellular patch-clamp recordings of RVLM neurons are technically impossible to perform in older rats.
Perspectives
Several lines of evidence have indicated that sympathetic nerve activity differs significantly between spontaneously hypertensive rats/SHRSPs and WKY rats, and this difference is one of the putative causes of hypertension in spontaneously hypertensive rats/SHRSPs. Because membrane potential of RVLM neurons determines the sympathetic tone, the present observation suggests that a gene (or genes) in the Chr-1 QTL is (are) responsible for the greater sympathetic tone observed in SHRSPs. Identification of the responsible gene(s) will improve our understanding of the role of the sympathetic nervous system in the pathogenesis of hypertension and promote the development of new therapeutic and preventive strategies for essential hypertension.
| Acknowledgments |
|---|
This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan.
Disclosures
None.
Received June 10, 2008; first decision June 28, 2008; accepted October 28, 2008.
| References |
|---|
|
|
|---|
2. Mashimo T, Nabika T, Matsumoto C, Tamada T, Ueno K, Sawamura M, Ikeda K, Kato N, Nara T, Yamori Y. Aging and salt-loading modulate blood pressure QTLs in rats. Am J Hypertens. 1999; 12: 1098–1104.[CrossRef][Medline] [Order article via Infotrieve]
3. Kato N, Mashimo T, Nabika T, Cui ZH, Ikeda K, Yamori Y. Genome-wide searches for blood pressure quantitative trait loci in the stroke-prone spontaneously hypertensive rat of a Japanese colony. J Hypertens. 2003; 21: 295–303.[CrossRef][Medline] [Order article via Infotrieve]
4. Kato N, Nabika T, Liang Y-Q, Mashimo T, Inomata H, Watanabe T, Yanai K, Yamori Y, Yazaki Y, Sasazuki T. Isolation of a chromosome 1 region affecting blood pressure and vascular disease traits in the stroke-prone rat model. Hypertension. 2003; 42: 1191–1197.
5. Cui ZH, Ikeda K, Kawakami K, Gonda T, Nabika T, Masuda J. Exaggerated response to restraint stress in rats congenic for the chromosome 1 blood pressure quantitative trait locus. Clin Exp Pharmacol Physiol. 2003; 30: 464–469.[CrossRef][Medline] [Order article via Infotrieve]
6. Cui ZH, Ikeda K, Kawakami K, Gonda T, Masuda J, Nabika T. Exaggerated response to cold stress in a congenic strain for the quantitative trait locus for blood pressure. J Hypertens. 2004; 22: 2103–2109.[CrossRef][Medline] [Order article via Infotrieve]
7. Yamazato M, Ohya Y, Nakamoto M, Sakima A, Tagawa T, Harada Y, Nabika T, Takishita S. Sympathetic hyperreactivity to air-jet stress in the chromosome 1 blood pressure quantitative trait locus congenic rats. Am J Physiol Regul Integr Comp Physiol. 2006; 290: R709–R714.
8. Dampney RA, Tan PS, Sheriff MJ, Fontes MA, Horiuchi J. Cardiovascular effects of angiotensin II in the rostral ventrolateral medulla: the push-pull hypothesis. Curr Hypertens Rep. 2007; 9: 22–27.[Medline] [Order article via Infotrieve]
9. Guyenet PG, Haselton JR, Sun MK. Sympathoexcitatory neurons of the rostroventrolateral medulla and the origin of the sympathetic vasomotor tone. Prog Brain Res. 1989; 81: 105–116.[Medline] [Order article via Infotrieve]
10. Mayorov DN, Head GA. AT1 receptors in the RVLM mediate pressor responses to emotional stress in rabbits. Hypertension. 2003; 41: 1168–1173.
11. Matsuura T, Kumagai H, Kawai A, Onimaru H, Imai M, Oshima N, Sakata K, Saruta T. Rostral ventrolateral medulla neurons of neonatal Wistar-Kyoto and spontaneously hypertensive rats. Hypertension. 2002; 40: 560–565.
12. Serikawa T. Colourful history of Japans rat resources. Nature. 2004; 429: 15.
13. Yao H, Cui ZH, Masuda J, Nabika T. Congenic removal of a QTL for blood pressure attenuates infarct size produced by middle cerebral artery occlusion in hypertensive rats. Physiol Genomics. 2007; 30: 69–73.
14. Oshima N, Kumagai H, Kawai A, Sakata K, Matsuura T, Saruta T. Three types of putative presympathetic neurons in the rostral ventrolateral medulla studied with rat brainstem-spinal cord preparation. Auton Neurosci. 2000; 84: 40–49.[CrossRef][Medline] [Order article via Infotrieve]
15. Onimaru H, Homma I. Whole cell recording from respiratory neurons in the medulla of brainstem-spinal cord preparations isolated from newborn rats. Pflugers Arch Eur J Physiol. 1992; 420: 399–406.[CrossRef][Medline] [Order article via Infotrieve]
16. Li Y-W, Guyenet PG. Angiotensin II decreases a resting K+ conductance in rat bulbospinal neurons of the C1 area. Circ Res. 1996; 78: 274–282.
17. Iigaya K, Kumagai H, Onimaru H, Kawai A, Oshima N, Onami T, Takimoto C, Kamayachi T, Hayashi K, Saruta T, Itoh H. Novel axonal projection from the caudal end of the ventrolateral medulla to the intermediolateral cell column. Am J Physiol Regul Integr Comp Physiol. 2007; 292: R927–R936.
18. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. Sydney, Australia: Academic Press; 1986.
19. Charron S, Duong C, Menard A, Roy J, Eliopoulos V, Lambert R, Deng AY. Epistasis, not numbers, regulates functions of clustered Dahl rat quantitative trait loci applicable to human hypertension. Hypertension. 2005; 46: 1300–1308.
20. Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev. 2000; 80: 135–172.
21. Nabika T, Kobayashi Y, Yamori Y. Congenic rats for hypertension: how useful are they for the hunting of hypertension genes? Clin Exp Pharmacol Physiol. 2000; 27: 251–256.[CrossRef][Medline] [Order article via Infotrieve]
22. Wang T, Nabika T, Notsu Y, Takabatake T. Sympathetic regulation of the renal functions in rats reciprocally congenic for chromosome 1 blood pressure quantitative trait locus. Hypertens Res. 2008; 31: 561–568.[Medline] [Order article via Infotrieve]
23. Sumners C, Fleegal MA, Zhu M. Angiotensin AT1 receptor signaling pathways in neurons. Clin Exp Pharmacol Physiol. 2002; 29: 483–490.[CrossRef][Medline] [Order article via Infotrieve]
24. Yang C, Kim HS, Seo H, Kim CH, Brunet JF, Kim KS. Paired-like homeodomain proteins, Phox2a and Phox2b, are responsible for noradrenergic cell-specific transcription of the dopamine beta-hydroxylase gene. J Neurochem. 1998; 71: 1813–1826.[Medline] [Order article via Infotrieve]
25. Swanson DJ, Zellmer E, Lewis EJ. The homeodomain protein Arix interacts synergistically with cyclic AMP to regulate expression of neurotransmitter biosynthetic genes. J Biol Chem. 1997; 272: 27382–27392.
26. Morin X, Cremer H, Hirsch MR, Kapur RP, Goridis C, Brunet JF. Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene phox2a. Neuron. 1997; 18: 411–423.[CrossRef][Medline] [Order article via Infotrieve]
27. ElShamy WM, Linnarsson S, Lee KF, Jaenisch R, Ernfors P. Prenatal and postnatal requirements of NT-3 for sympathetic neuroblast survival and innervation of specific targets. Development. 1996; 122: 491–500.[Abstract]
28. DeFea K. Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction. Br J Pharmacol. 2008; 153: s298–s309.
29. Dai X, Cao X, Kreulen DL. Superoxide anion is elevated in sympathetic neurons in DOCA-salt hypertension via activation of NADPH oxidase. Am J Physiol. 2006; 290: H1019–H1026.
30. Ehrengruber MU, Kato A, Inokuchi D, Hennou S. Homer/Vesl proteins and their roles in CNS neurons. Mol Neurobiol. 2004; 29: 213–227.[CrossRef][Medline] [Order article via Infotrieve]
31. Hinojos CA, Boerwinkle E, Fornage M, Eoris PA. Combined genealogical, mapping, and expression approaches to identify SHR hypertension genes. Hypertension. 2005; 45: 698–704.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |